Accuray Incorporated
ARAY Healthcare Medical Devices
Accuray Incorporated’s revenue for fiscal 2026 (year ended June 2026) was $401.9 million, down 12.3% from fiscal 2025. In the quarter to June 2026, revenue fell 20.9%, EPS fell 300.0%, free cash flow grew 117.8% and total debt rose 18.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
Follow ARAY
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
63.92 | 41.87 | 38.53 | 41.23 |
Receivables |
54.38 | 60.96 | 64.57 | 67.41 | |
Inventory |
155.50 | 150.96 | 156.63 | 147.08 | |
Total current assets |
303.60 | 292.39 | 293.22 | 287.78 | |
Property, Plant, Equpment (Net) |
29.01 | 29.26 | 29.00 | 27.32 | |
Long-Term Investments |
4.01 | 5.80 | 6.32 | 5.02 | |
Goodwill and Intangible Assets (Total) |
57.82 | 57.85 | 57.88 | 57.91 | |
Long-term assets (Other) |
30.27 | 31.91 | 32.28 | 38.14 | |
Total non-current assets |
153.21 | 155.62 | 154.39 | 155.90 | |
Total Assets |
456.82 | 448.01 | 447.60 | 443.68 | |
Notes Payable |
12.85 | 11.11 | 11.16 | 1.50 | |
Accounts Payable |
42.40 | 43.52 | 52.81 | 40.55 | |
Accrued Expenses |
13.91 | 14.93 | 16.97 | 15.67 | |
Current Revenue (Deferred) |
79.63 | 78.98 | 78.94 | 82.81 | |
Other current liabilities |
12.09 | 11.85 | 11.37 | 10.40 | |
Total current liabilities |
194.61 | 199.44 | 205.84 | 191.41 | |
Long Term Debt (Total) |
127.32 | 124.78 | 134.02 | 146.37 | |
Non-current Revenue (Deferred) |
25.82 | 27.61 | 27.00 | 28.53 | |
Non-current Liabilities (Other) |
15.72 | 12.58 | 10.04 | 7.90 | |
Total non-current liabilities |
200.34 | 195.15 | 200.05 | 210.57 | |
Total liabilities |
394.95 | 394.59 | 405.90 | 401.98 | |
Additional Paid In Capital |
604.68 | 609.41 | 610.78 | 613.56 | |
Common Stock (Net) |
0.11 | 0.12 | 0.12 | 0.12 | |
Retained Earnings |
(540.95) | (554.72) | (566.52) | (568.47) | |
Common Equity (Total) |
61.87 | 53.42 | 41.71 | 41.70 | |
Shareholders Equity (Total) |
61.87 | 53.42 | 41.71 | 41.70 | |
Shareholders Equity and Liabilities (Total) |
456.82 | 448.01 | 447.60 | 443.68 | |
Shares (Common) |
113.28 | 118.79 | 118.93 | 119.43 | |
Shareholders Equity (Tangible) |
4.05 | (4.43) | (16.17) | (16.21) | |
Net Debt |
63.40 | 82.91 | 95.49 | 105.14 | |
Total Debt |
127.32 | 124.78 | 134.02 | 146.37 |